Cathelicidin LL-37: A central factor in the pathogenesis of inflammatory dermatoses? [Cathelicidin LL-37: Ein zentraler faktor in der pathogenese entzündlicher dermatosen?]

被引:0
|
作者
Schauber J. [1 ,2 ]
Ruzicka T. [1 ]
Rupec R.A. [1 ]
机构
[1] Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität München, 80337 München
来源
Der Hautarzt | 2008年 / 59卷 / 1期
关键词
Antimicrobial peptides; Atopic eczema; Cathelicidin; Psoriasis; Rosacea;
D O I
10.1007/s00105-007-1457-z
中图分类号
学科分类号
摘要
Keratinocytes produce and secrete antimicrobial peptides which function as endogenous antibiotics and as signaling molecules within the cutaneous innate immune system. Recent studies demonstrate that the antimicrobial peptide cathelicidin LL-37 plays an important role in the pathogenesis of atopic eczema, rosacea and psoriasis. Whereas skin in atopic eczema shows decreased cathelicidin expression which leads to increased susceptibility to superinfection in those patients, overabundant expression of cathelicidin peptide fragments causes inflammation in rosacea. Finally, in psoriasis cathelicidin peptide binds to self DNA which triggers an autoimmune response. These studies demonstrate the role of cathelicidin as a central factor in the pathogenesis of cutaneous inflammation. Therapies targeting cathelicidin expression and function could lead to new treatments for these diseases. © 2007 Springer Medizin Verlag.
引用
收藏
页码:72 / 74
页数:2
相关论文
共 50 条
  • [21] Antibiofilm properties of cathelicidin LL-37: an in-depth review
    Hamed Memariani
    Mojtaba Memariani
    World Journal of Microbiology and Biotechnology, 2023, 39
  • [22] LOSS OF CATHELICIDIN (LL-37) IS ASSOCIATED WITH COLORECTAL CANCER PROGRESSION
    Porter, Ross J.
    Murray, Graeme I.
    Wang, Ji M.
    Yoshimura, Teizo
    McLean, Mairi H.
    GUT, 2018, 67 : A199 - A199
  • [23] Multifunctional roles of human cathelicidin (LL-37) at the ocular surface
    Huang, Ling C.
    Petkova, Tihomira D.
    Reins, Rose Y.
    Proske, Rita J.
    McDermott, Alison M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (06) : 2369 - 2380
  • [24] Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity
    Otte, Jan-Michel
    Zdebik, Anna-Elisabeth
    Brand, Stephan
    Chromik, Ansgar M.
    Strauss, Sarah
    Schmitz, Frank
    Steinstraesser, Lars
    Schmidt, Wolfgang E.
    REGULATORY PEPTIDES, 2009, 156 (1-3) : 104 - 117
  • [25] Modulation of exogenous antibiotic activity by host cathelicidin LL-37
    Leszczynska, Katarzyna
    Namiot, Andrzej
    Janmey, Paul A.
    Bucki, Robert
    APMIS, 2010, 118 (11) : 830 - 836
  • [26] Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide
    Golec, Marcin
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2007, 14 (01) : 1 - 4
  • [27] Study of cathelicidin (LL-37) immunoexpression in the skin of vitiligo patients
    Elgarhy, Lamia Hamouda
    Ramadan, Basma Ramadan Refaey
    Sallam, Fersan Abd Allah
    Iskandarani, Dalya Ayman
    Hewedy, El-Sayed Shaaban
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [28] Human cathelicidin LL-37 prevents bacterial biofilm formation
    Jacobsen, Andreas S.
    Jenssen, Havard
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (12) : 1587 - 1599
  • [29] The role of the microenvironment protein cathelicidin LL-37 in pancreatic ductal adenocarcinoma
    Sainz, Bruno, Jr.
    Frias, Javier
    Cioffi, Michele
    Alcala, Sonia
    Heeschen, Christopher
    CANCER RESEARCH, 2013, 73
  • [30] LL-37, the only human member of the cathelicidin family of antimicrobial peptides
    Durr, Ulrich H. N.
    Sudheendra, U. S.
    Ramamoorthy, Ayyalusamy
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09): : 1408 - 1425